{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:31:46Z","timestamp":1707525106964},"reference-count":12,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,4,25]]},"DOI":"10.7759\/cureus.38122","type":"journal-article","created":{"date-parts":[[2023,4,25]],"date-time":"2023-04-25T19:42:08Z","timestamp":1682451728000},"source":"Crossref","is-referenced-by-count":0,"title":["Coronavirus Disease 2019 Vaccine-Induced Flare-Up of Severe Bronchial Asthma Previously Controlled With Dupilumab: A Case Report"],"prefix":"10.7759","author":[{"given":"Toshiyuki","family":"Sumi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kentaro","family":"Kodama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hirotaka","family":"Nishikiori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yusuke","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hirofumi","family":"Chiba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2110345","article-title":"Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine through 6 months","volume":"385","author":"Thomas SJ","year":"2021","unstructured":"Thomas SJ, Moreira ED Jr, Kitchin N, et al.. Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine through 6 months. N Engl J Med. 2021, 385:1761-73. 10.1056\/NEJMoa2110345","journal-title":"N Engl J Med"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2021.15072","article-title":"Surveillance for adverse events after COVID-19 mRNA vaccination","volume":"326","author":"Klein NP","year":"2021","unstructured":"Klein NP, Lewis N, Goddard K, et al.. Surveillance for adverse events after COVID-19 mRNA vaccination. JAMA. 2021, 326:1390-9. 10.1001\/jama.2021.15072","journal-title":"JAMA"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2021.09.026","article-title":"COVID vaccination and asthma exacerbation: might there be a link?","volume":"112","author":"Colaneri M","year":"2021","unstructured":"Colaneri M, De Filippo M, Licari A, et al.. COVID vaccination and asthma exacerbation: might there be a link?. Int J Infect Dis. 2021, 112:243-6. 10.1016\/j.ijid.2021.09.026","journal-title":"Int J Infect Dis"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2022.09.019","article-title":"Acute asthma exacerbation due to the SARS-CoV-2 vaccine (Pfizer-BioNTech BNT162b2 messenger RNA COVID-19 vaccine [Comirnaty(\u24c7)])","volume":"124","author":"Ando M","year":"2022","unstructured":"Ando M, Satonaga Y, Takaki R, et al.. Acute asthma exacerbation due to the SARS-CoV-2 vaccine (Pfizer-BioNTech BNT162b2 messenger RNA COVID-19 vaccine [Comirnaty(\u24c7)]). Int J Infect Dis. 2022, 124:187-9. 10.1016\/j.ijid.2022.09.019","journal-title":"Int J Infect Dis"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-020-03102-w","article-title":"Publisher correction: COVID-19 vaccine BNT162b1 elicits human antibody and T(H)1 T cell responses","volume":"590","author":"Sahin U","year":"2021","unstructured":"Sahin U, Muik A, Derhovanessian E, et al.. Publisher correction: COVID-19 vaccine BNT162b1 elicits human antibody and T(H)1 T cell responses. Nature. 2021, 590:E17. 10.1038\/s41586-020-03102-w","journal-title":"Nature"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.21176","article-title":"Eosinophilic granulomatosis with polyangiitis diagnosed in an elderly female after the second dose of mRNA vaccine against COVID-19","volume":"14","author":"Ibrahim H","year":"2022","unstructured":"Ibrahim H, Alkhatib A, Meysami A. Eosinophilic granulomatosis with polyangiitis diagnosed in an elderly female after the second dose of mRNA vaccine against COVID-19. Cureus. 2022, 14:e21176. 10.7759\/cureus.21176","journal-title":"Cureus"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.4103\/2045-9912.326003","article-title":"Acute asthma exacerbation after SARS-CoV-2 vaccine (Sinovac\u00ae): a case report","volume":"12","author":"Uzer F","year":"2022","unstructured":"Uzer F, Cilli A. Acute asthma exacerbation after SARS-CoV-2 vaccine (Sinovac\u00ae): a case report. Med Gas Res. 2022, 12:67-8. 10.4103\/2045-9912.326003","journal-title":"Med Gas Res"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics12071555","article-title":"Current evidence in SARS-CoV-2 mRNA vaccines and post-vaccination adverse reports: knowns and unknowns","volume":"12","author":"Mouliou DS","year":"2022","unstructured":"Mouliou DS, Dardiotis E. Current evidence in SARS-CoV-2 mRNA vaccines and post-vaccination adverse reports: knowns and unknowns. Diagnostics (Basel). 2022, 12:1555. 10.3390\/diagnostics12071555","journal-title":"Diagnostics (Basel)"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.02857-2020","article-title":"COVID-19 and biologics in severe asthma: data from the Belgian Severe Asthma Registry","volume":"56","author":"Hanon S","year":"2020","unstructured":"Hanon S, Brusselle G, Deschampheleire M, et al.. COVID-19 and biologics in severe asthma: data from the Belgian Severe Asthma Registry. Eur Respir J. 2020, 56:2002857. 10.1183\/13993003.02857-2020","journal-title":"Eur Respir J"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1111\/all.14532","article-title":"COVID-19 in Severe Asthma Network in Italy (SANI) patients: clinical features, impact of comorbidities and treatments","volume":"76","author":"Heffler E","year":"2021","unstructured":"Heffler E, Detoraki A, Contoli M, et al.. COVID-19 in Severe Asthma Network in Italy (SANI) patients: clinical features, impact of comorbidities and treatments. Allergy. 2021, 76:887-92. 10.1111\/all.14532","journal-title":"Allergy"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2021.06.006","article-title":"COVID-19 risk and outcomes in adult asthmatic patients treated with biologics or systemic corticosteroids: nationwide real-world evidence","volume":"148","author":"Adir Y","year":"2021","unstructured":"Adir Y, Humbert M, Saliba W. COVID-19 risk and outcomes in adult asthmatic patients treated with biologics or systemic corticosteroids: nationwide real-world evidence. J Allergy Clin Immunol. 2021, 148:361-367.e13. 10.1016\/j.jaci.2021.06.006","journal-title":"J Allergy Clin Immunol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines9080853","article-title":"COVID-19 vaccination in patients with severe asthma on biologic treatment: safety, tolerability, and impact on disease control","volume":"9","author":"Caminati M","year":"2021","unstructured":"Caminati M, Guarnieri G, Batani V, et al.. COVID-19 vaccination in patients with severe asthma on biologic treatment: safety, tolerability, and impact on disease control. Vaccines (Basel). 2021, 9:853. 10.3390\/vaccines9080853","journal-title":"Vaccines (Basel)"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/151195-coronavirus-disease-2019-vaccine-induced-flare-up-of-severe-bronchial-asthma-previously-controlled-with-dupilumab-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:56:07Z","timestamp":1707508567000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/151195-coronavirus-disease-2019-vaccine-induced-flare-up-of-severe-bronchial-asthma-previously-controlled-with-dupilumab-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,25]]},"references-count":12,"URL":"https:\/\/doi.org\/10.7759\/cureus.38122","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4,25]]}}}